Please read and confirm that you accept the following terms and conditions
ELECTRONIC VERSIONS OF THE MATERIALS YOU ARE SEEKING TO ACCESS ARE BEING MADE AVAILABLE ON THIS WEBPAGE BY SHIELD THERAPEUTICS PLC IN GOOD FAITH AND FOR INFORMATION PURPOSES ONLY.
THESE MATERIALS ARE NOT INTENDED FOR, DIRECTED AT OR ACCESSIBLE BY PERSONS LOCATED IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
Please read this notice carefully, it applies to all persons who view this webpage. Please note that the disclaimer set out below may be altered or updated. You should read it in full each time you visit the site.
Viewing the materials you seek to access may not be lawful in certain jurisdictions. In other jurisdictions, only certain categories of person may be allowed to view such materials. Any person who wishes to view these materials must first satisfy themselves that they are not subject to any local requirements that prohibit or restrict them from doing so. Any failure to comply with any such restrictions may constitute a violation of the securities laws or regulations of such jurisdiction.
In particular, it is not intended, subject to certain limited exceptions where not prohibited by applicable law and regulation, that any offering of the securities mentioned in such materials (the "Securities"), by Shield Therapeutics plc would be made, or any documentation be sent directly or indirectly, in or into the United States, Canada, Australia, Japan or the Republic of South Africa or any jurisdiction in which such sale or distribution would be unlawful.
None of the information contained on the following pages nor any copy thereof may be taken or transmitted directly or indirectly, in or into the united States, Canada, Australia, Japan or the Republic of South Africa or any jurisdiction in which the distribution or release would be unlawful. Persons located in any such jurisdiction are not permitted to access this section of the website and should exit it immediately.
These materials do not constitute or form a part of any offer or solicitation to purchase or subscribe for Securities in the United States or in any jurisdiction in which such offer or solicitation would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The Securities have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act") and may not be offered, sold, resold or distributed, directly or Indirectly, in or into United States, except pursuant to an applicable exemption from the registration requirements of the Securities Act and in compliance with the securities laws of any state or other jurisdiction of the United States. There will be no public offering of such Securities in the United States.
If you are not permitted to view materials on this webpage or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.
Basis of access
Access to electronic versions or these materials is being made available on this webpage by Shield Therapeutics plc in good faith and/or information purposes only. Any person seeking access to this webpage represents and warrants to Shield Therapeutics plc that they are doing so for information purposes only. Making press announcements and other documents available in electronic format does not constitute an offer to sell or the solicitation of an offer to buy the Securities. Further; it does not constitute a recommendation by Shield Therapeutics plc or any other party to sell or buy the Securities.
Confirmation of understanding and acceptance of disclaimer
To confirm that you (a) have read, understand and agree to comply with all of the restrictions set forth above, (b) you are not accessing this website from within the United States, Canada, Australia, Japan or the Republic of South Africa or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction, and (c) you are not a US Person as defined under Regulation S of the Securities Act, and (d) are permitted to proceed to electronic versions of the information and materials on this portion of the website, please select "I understand and agree" below.